Clarivate CLVT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Academia & Government Group | $295M-5.5% | $312.3M-6.1% | $332.5M+4.4% | $318.5M+5.2% | $302.7M-11.7% | |
| Intellectual Property Group | $197.2M-4.5% | $206.4M+4.3% | $197.8M-2.3% | $202.5M+5.1% | $192.7M-7.8% | |
| Life Sciences & Healthcare | $93.3M-5.1% | $98.3M+5.9% | $92.8M-7.6% | $100.4M+2.1% | $98.3M-11.4% | |
| Revenue by Product | ||||||
| Re-occurring Revenues | $108.6M-4.8% | $114.1M+8.4% | $105.3M-3.3% | $108.9M+2.8% | $105.9M-5.4% | |
| Recurring Revenues | $506.1M— | —— | —— | —— | $494.5M-3.8% | |
| Subscription revenues | $397.5M-2.0% | $405.8M+0.1% | $405.4M-0.1% | $405.7M+4.4% | $388.6M-4.5% | |
| Transactional and other revenues | $79.4M-18.2% | $97.1M-13.6% | $112.4M+5.2% | $106.8M+7.7% | $99.2M-31.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Clarivate break its business down?
- Clarivate (CLVT) reports revenue by business across 3 parts — Academia & Government Group, Intellectual Property Group and Life Sciences & Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Clarivate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Clarivate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
